Neuralink has received the green light to initiate recruitment for its inaugural human clinical trial, dubbed the PRIME Study (Precise Robotically Implanted Brain-Computer Interface).
The move comes after a successful lawsuit by Kansas Attorney General Kris Kobach, challenging the previous provision that permitted individuals to alter their gender on state documentation.
